Eléphant Vert 宣布首席执行官继任计划

Peter Braendle (left) will hand over the role of Group CEO to Charles Marchand effective 1 November 2026 as part of a planned CEO succession at Eléphant Vert.
绿象 (EV), the specialist in agricultural biosolutions, today announces that Peter Braendle will hand over the role of Group CEO to Charles Marchand effective 1 November 2026 as part of a planned CEO succession.
Since becoming Group CEO in 2020, Peter Braendle has led Eléphant Vert through an important phase of transformation and strategic refocusing. He has strengthened the Group’s organization and its operational and financial foundations, divested non-core activities, repositioned the portfolio towards biocontrol and high-value biosolutions, expanded the Group’s presence in Europe, Africa and beyond, and led the acquisition and integration of businesses including Lipofabrik and BIO3G. He has also driven greater focus and alignment across the Group’s R&D and product portfolio.
Charles Marchand has built his career in the agricultural inputs and biosolutions industry, including senior leadership roles at Olmix and TIMAC AGRO/Groupe Roullier. His experience spans commercial development, international management, and the leadership of agricultural product and business portfolios.
Building on the progress achieved over recent years, Eléphant Vert enters this next chapter well positioned to advance the adoption of effective biosolutions for farmers and agricultural partners and to continue its international development.
Peter Braendle, Group CEO of Eléphant Vert, said:
“I am proud of what we have achieved together over the past years, and of the transformation of Eléphant Vert into a more focused and innovative Group. After six years, and with the Group well positioned for its next stage of development, I concluded together with the Board that this is the right moment to plan a succession. I am glad we have found in Charles someone whose international and commercial experience in our sector will be very valuable for Eléphant Vert’s continued development, and I wish him and the entire teams continued success.”
Ulrich Burkhard, Chairman of the Board of Eléphant Vert, said:
“On behalf of the Board, I would like to sincerely thank Peter for his leadership, commitment, and achievements over the past six years. He has led the Group with rigor and integrity through a demanding period of transformation, sharpened its strategic focus and built both a strong platform and teams for the future. On that foundation, the Group will continue to develop its commercial activities, product portfolio, and international presence under Charles, as the incoming CEO. Charles combines deep sector expertise with a strong commercial track record and international leadership experience, and we are very pleased to welcome him to lead this next chapter.”
Charles Marchand, Incoming CEO, said:
“I am delighted to join Eléphant Vert and look forward to building on the foundation Peter has created. Eléphant Vert has differentiated technologies, products with proven effectiveness in the field, and expertise in a market with significant long-term potential. My priority will be to work with the teams to continue expanding Eléphant Vert’s commercial reach in Europe and internationally, and to bring effective biosolutions to more farmers.”